Intel Upsizes Share Sale to $20 Billion for AI Expansion

Intel has expanded its stock offering to raise $20 billion, pricing shares at $95 apiece, as the chipmaker accelerates investments in artificial intelligence infrastructure. The company originally planned a $15 billion sale, but strong investor demand allowed it to upsize the offering, according to sources familiar with the matter.

The move comes amid a sharp rally in Intel's shares, driven by optimism over its turnaround strategy under CEO Pat Gelsinger. The company has been ramping up its foundry business and AI chip portfolio to compete with rivals like Nvidia and AMD.

Why the Upsize?

Intel's decision to increase the offering size reflects robust appetite from institutional investors, who see the company as a potential beneficiary of the AI boom. The $95 per share price represents a modest discount to recent trading levels, a common practice in secondary offerings to attract buyers.

The funds raised will be used for capital expenditures, including building new fabrication plants and expanding advanced packaging capabilities. Intel has committed to investing heavily in manufacturing capacity to regain technological leadership.

AI Demand Accelerates

The AI chip market is growing at a breakneck pace, with data center operators scrambling for high-performance processors. Intel's Gaudi accelerators and upcoming Xeon server chips are expected to capture a slice of this demand, though the company still lags behind Nvidia in market share.

Analysts note that Intel's foundry business, which makes chips for other companies, could also benefit from AI-related orders. The company has already signed deals with several major customers, though it has not disclosed names.

Stock Rally and Turnaround Hopes

Intel's stock has surged over the past year, recovering from a prolonged slump. The turnaround plan, which includes cost cuts and a focus on manufacturing innovation, has won over some skeptical investors.

However, the company still faces significant challenges, including intense competition and execution risks. The $20 billion infusion provides a cushion, but it also dilutes existing shareholders. The offering is expected to close within days, with proceeds hitting Intel's balance sheet by the end of the month.

What to Watch

Investors will be watching Intel's next earnings report for updates on AI chip sales and foundry customer wins. The company has also hinted at further capital raises if needed, though no formal plans have been announced.

As the AI race intensifies, Intel's ability to convert this cash into market share will be the key test. The stock's trajectory in the coming quarters will depend on tangible progress, not just promises.